您的位置:首页 > 推荐期刊 > 期刊详情
推荐期刊
Cancer immunology immunotherapy
分享到:

影响因子:3.637

ISSN:0340-7004

出版社:Springer Verlag

出版地:Berlin

出版国家:Germany

刊期:月刊

创刊时间:1982

语种:英文

审稿周期:平均1月

中科院分区:2

投稿命中率:命中率约30.90%较易

国外数据收录:IMIM

中国收录文章数:99

5年影响因子:3.554

研究领域:免疫治疗、肿瘤

官方链接:http://link.springer.com/journal/262

投稿须知:http://link.springer.com/journal/262

期刊介绍:

Keeping readers informed of the latest research results in the fields of oncology and immunology has always been one of the main services provided by Cancer Immunology Immunotherapy. To make this service even more comprehensive the scope of the journal was expanded some years ago to include more of the progres being made in the various fields of biology concerned with biological response modifiers thus enabling readers to keep up to date on the latest advances in our understanding of tumor-host interactions. Tumor immunologists clinical oncologists virologists and medical microbiologists involved in the development of methods of treatment and therapies for cancer patients will have access to the information contained in this journal. The journal publishes short editorials (including "position papers") general reviews original articles and short communications providing a forum for the most recent experimental and clinical advances in tumor immunology.

同领域期刊名称 影响因子

维普投稿-SCI专栏论文服务由广州品恒信息科技有限公司独立运营并承担相应的责任与义务

友情链接:维普网 | 维普投稿平台 | 维普论文检测 | 维普论文选题